Nicox S.A. (ALCOX.PA)

EUR 0.22

(-4.48%)

Net Debt Summary of Nicox S.A.

Nicox S.A.'s latest annual net debt in 2023 was 13.89 Million EUR , up 879.25% from previous year.
Nicox S.A.'s latest quarterly net debt in 2023 FY was 13.89 Million EUR , up 879.25% from previous quarter.
Nicox S.A. reported annual net debt of -1.78 Million EUR in 2022, up 91.29% from previous year.
Nicox S.A. reported annual net debt of -20.46 Million EUR in 2021, up 27.23% from previous year.
Nicox S.A. reported quarterly net debt of 13.89 Million EUR for 2023 Q4, down 0.0% from previous quarter.
Nicox S.A. reported quarterly net debt of 2.14 Million EUR for 2023 Q2, up 56.08% from previous quarter.

Annual Net Debt Chart of Nicox S.A. (2023 - 2019)

Historical Annual Net Debt of Nicox S.A. (2023 - 2019)

Year	Net Debt	Net Debt Growth
2023	13.89 Million EUR	879.25%
2022	-1.78 Million EUR	91.29%
2021	-20.46 Million EUR	27.23%
2020	-28.12 Million EUR	0.0%
2019	- EUR	0.0%

Year	Net Debt	Net Debt Growth
2023 FY	13.89 Million EUR	879.25%
2023 Q4	13.89 Million EUR	0.0%
2023 Q2	2.14 Million EUR	56.08%
2023 Q1	1.37 Million EUR	177.01%
2022 Q4	-1.78 Million EUR	0.0%

Peer Net Debt Comparison of Nicox S.A.

Name	Net Debt	Net Debt Difference
European Medical Solutions	13.93 Million EUR	0.266%
FERMENTALG	4.19 Million EUR	-231.362%
argenx SE	-1.83 Billion EUR	100.756%
BioSenic S.A.	28.04 Million EUR	50.456%
Celyad Oncology SA	-6.1 Million EUR	327.696%
Hyloris Pharmaceuticals SA	-25.11 Million EUR	155.328%
Onward Medical N.V.	-12.89 Million EUR	207.756%
Oxurion NV	10.71 Million EUR	-29.729%
PHAXIAM Therapeutics S.A.	-275 Thousand EUR	5152.364%
Financière de Tubize SA	78.62 Million EUR	82.329%
UCB SA	2.17 Billion EUR	99.362%